Auteur: Carli Wischhoff

In the latest Dutch Dragons episode, Roald Kruit shares his personal journey – from co-founding Mendix to founding Yamicc. It’s a story about entrepreneurship, technology, and above all, the conviction that we can (and should) do better when it comes to clinical research for rare cancers. Yamicc was born from the belief that research can…

Clinical trials are the engine of medical progress.But today, they still take a lot of time, are relatively expensive and aren’t built for flexibility.In rare cancer, where time is limited and patient populations are small, traditional trials often struggle to deliver meaningful results. Much of that comes down to infrastructure: Setting up studies takes months.…

In rare cancer research, collaboration is essential. And the willingness to work together is there. But supportive infrastructure is missing. Clinical studies take place within few hospitals, thereby not including all available patients. That limits scale, makes data hard to combine, and slows down progress.Differences in research design, legal frameworks, data storage and technology make…

Why rare cancers need a different approach One in two people get cancer.One in five cancer patients is diagnosed with a rare form of the disease. But while oncology has advanced rapidly, traditional research models still fall short for rare cancer patients, because they weren’t built for this kind of complexity. Rare cancers are often…